Top medical experts have raised concerns over the misuse of GLP-1 receptor agonists as lifestyle enhancers, warning that such practices could lead to shortages for high-risk patients.
Hornbill TV
2026-03-30 14:27:13
India’s drug regulator has intensified surveillance of the supply chain of GLP-1 drugs, used for treating type 2 diabetes and obesity, amid growing concerns over their misuse and unauthorized sale.
2026-03-24 13:12:54
Be the first to receive special offers and the latest news.